1887

Abstract

SUMMARY

Proteins consisting of one, two or four copies of the amino acid sequence 137 to 162, which contains the major immunogenic site of VP1 of foot-and-mouth disease virus, attached to the N-terminus of -galactosidase have been expressed in cells. In guinea-pigs the protein containing one copy (P71) of the viral determinant elicited only low levels of neutralizing antibody whereas protective levels were elicited by the proteins containing two (P72) or four (P74) copies of the determinant. Single inoculations of the P72 and P74 proteins containing as little as 2 μg or 0·8 μg of peptide respectively were sufficient to protect all the animals against challenge infection. Moreover, the equivalent of 40 μg of peptide in P74 protected pigs against challenge infection after one inoculation.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-68-12-3137
1987-12-01
2024-11-05
Loading full text...

Full text loading...

/deliver/fulltext/jgv/68/12/JV0680123137.html?itemId=/content/journal/jgv/10.1099/0022-1317-68-12-3137&mimeType=html&fmt=ahah

References

  1. Bachrach H. L., Moore D. M., Mckercher P. D., Polatnick J. 1975; Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus. Journal of Immunology 115:1636–1641
    [Google Scholar]
  2. Bittle I. L., Houghten R. A., Alexander H., Shinnick T. M., Sutcliffe J. G., Lerner R. A., Rowlands D. J., Brown F., Rowlands D. J. 1982; Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature; London: 29830–33
    [Google Scholar]
  3. Broekhuijsen M. P., Blom T., Kottenhagen M., Pouwels P. H., Meloen R. H., Barteling S. J., Engel-Valk B. E. 1986a; Synthesis of fusion proteins containing antigenic determinants of foot-and-mouth disease virus. Vaccine 4:119–124
    [Google Scholar]
  4. Broekhuijsen M. P., Blom T., Vanrijn J., Pouwels P. H., Klasen E. A., Fasbender M. J., Enger-Valk B. E. 1986b; Synthesis of fusion proteins with multiple copies of an antigenic determinant of foot-and-mouth disease virus. Gene 49:189–197
    [Google Scholar]
  5. Brown F. 1985; Vaccination against foot-and-mouth disease: past, present and future. Annals Institut Pasteur 136E:547–552
    [Google Scholar]
  6. Dimarchi R., Brooke G., Gale C., Cracknell V., Doel T., Mowat N. 1986; Protection of cattle against foot- and-mouth disease by a synthetic peptide. Science 232:639–641
    [Google Scholar]
  7. Enea V., Arnot D., Schmidt E. C., Cochrane A., Gwadz R. 1984; Circumsporozoite gene of Plasmodium cynomolgy(Gombak): cDNA cloning and expression of the repetitive circumsporozoite epitope. Proceedings of the National Academy of Sciences U.S.A.: 81:7520–7524
    [Google Scholar]
  8. Francis M. J., Black L. 1983; Antibody response in pig nasal fluid and serum following foot-and-mouth disease infection or vaccination. Journal of Hygiene 91:329–334
    [Google Scholar]
  9. Francis M. J., Fry C., Rowlands D. J., Brown F., Bittle J. L., Houghten R. A., Lerner R. A. 1985a; Priming with peptides of foot-and-mouth disease virus. In Vaccines 85 pp 203–210 Lerner R. A., Chanock R. M., Brown F. Edited by New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  10. Francis M. J., Fry C. M., Rowlands D. J., Brown F., Bittle J. L., Houghten R. A., Lerner R. A. 1985b; Immunological priming with synthetic peptides of foot-and-mouth disease virus. Journal of General Virology 66:2347–2354
    [Google Scholar]
  11. Francis M. J., Fry C. M., Clarke B. E., Rowlands D. I., Brown F., Bittle J. L., Houghten R. A., Lerner R. A. 1987a; A foot-and-mouth disease virus synthetic peptide containing B and T cell determinants. In Vaccines 87 pp 60–67 Chanock R. M., Ginsberg H., Lemer R. A., Brown F. Edited by New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  12. Francis M. J., Fry C. M., Rowlands D. J., Bittle J. L., Houghten R. A., Lerner R. A., Brown F. 1987b; Immune response to uncoupled peptides of foot-and-mouth disease. Immunology 61:1–6
    [Google Scholar]
  13. Frenkel H. S. 1947; La culture de virus de la fievre aphteuse sur l’épithelium de la langue des bovidés. Bulletin. Office international des épizooties 28:155–162
    [Google Scholar]
  14. Kaaden O. R., Adam K.-H., Strohmaier K. 1977; Induction of neutralizing antibodies and immunity in vaccinated guinea pigs by cyanogen bromide-peptides of VP3of foot-and-mouth disease virus. Journal of General Virology 34:397–400
    [Google Scholar]
  15. Kleid D. G., Yansura D. G., Small B., Dowbenko D., Moore D. M., Grubman M. J., Mckercher P. D., Morgan D. O., Robertson B. H., Bachrach H. L. 1981; Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science 214:1125–1129
    [Google Scholar]
  16. Kleid D. G., Dowbenko D. J., Bock L. A., Hotlin M. E., Jackson M. L., Patzer E. J., Shine S. J., Weddell G. N., Yansura D. G., Morgan D. O., Mckercher P. D., Moore D. M. 1985; Production of recombinant vaccines from microorganisms: vaccine for foot-and-mouth disease. In Microbiology 1985 pp 405–408 Leive L. Edited by Washington D.C.: American Society for Microbiology;
    [Google Scholar]
  17. Krzych U. A., Fowler A. V., Miller A., Sercarz E. E. 1982; Repertoires of T cells directed against a large protein antigen, β-galactosidase. Journal of Immunology 128:1529–1534
    [Google Scholar]
  18. Kurz C., Forss S., Kupper H., Strohmaier K., Schaller H. 1981; Nucleotide sequence and corresponding amino acid sequence of the gene for the major antigen of foot-and-mouth disease virus. Nucleic Acids Research 9:1919–1931
    [Google Scholar]
  19. Laporte J., Groslaude J., Wantyghem J., Bernard S., Rouze P. 1973; Neutralisationen culturecellulaire du pouvoir infectieux du virus de la fievre aphteuse par des serums provenant de pores immunises a 1’aide d’une proteīne virale purifiée. Comptes rendu hebdomadaire des séances de l’Academie des sciences, Série D 276:3399–3401
    [Google Scholar]
  20. Macpherson I., Stoker M. 1962; Polyoma transformation of hamster cell clones - an investigation of genetic factors affecting cell competence. Virology 16:147–151
    [Google Scholar]
  21. Manca F., Kunkl A., Fenoglio D., Fowler A., Sercarz E., Celada F. 1985; Constraints in T-B cooperation related to epitope topology on E. coli/i-galactosidase. European Journal of Immunology 15:345–350
    [Google Scholar]
  22. Mowat G. N., Chapman W. G. 1962; Growth of foot-and-mouth disease virus in a fibroblastic cell derived from hamster kidneys. Nature; London: 194253–255
    [Google Scholar]
  23. Parry N. R., Ouldridge E. J., Barnett P. V., Rowlands D. J., Brown F., Bittle J. L., Houghten R. A., Lerner R. A. 1985; Identification of neutralizing epitopes of foot-and-mouth disease virus. In Vaccines 85 pp 211–216 Lerner R. A., Chanock R. M., Brown F. Edited by New York: Cold Harbor Laboratory;
    [Google Scholar]
  24. Pfaff E., Mussgay M., Bohm H. O., Schulz G. E., Schaller H. 1982; Antibodies against a preselected peptide recognize and neutralize foot-and-mouth disease virus. EMBO Journal 1:869–874
    [Google Scholar]
  25. Sangar D. V., Black D. N., Rowlands D. J., Brown F. 1977; Biochemical mapping of the foot-and-mouth disease virus genome. Journal of General Virology 35:281–297
    [Google Scholar]
  26. Strohmaier K., Franze R., Adam K.-H. 1982; Location and characterization of the antigenic portion of the FMDV immunizing protein. Journal of General Virology 59:295–306
    [Google Scholar]
  27. Voller A., Bidwell D. E. 1976; Enzyme immunoassays for antibodies in measles, cytomegalovirus infections and after rubella vaccination. British Journal of Experimental Pathology 57:243–247
    [Google Scholar]
  28. Wild T. F., Burroughs J. N., Brown F. 1969; Surface structure of foot-and-mouth disease virus. Journal of General Virology 4:313–320
    [Google Scholar]
  29. Winther M. D., Allen G., Bomford R. H., Brown F. 1986; Bacterially expressed antigenic peptide from foot- and-mouth disease virus capsid elicits variable immunologic responses in animals. Journal of Immunology 136:1835–1840
    [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-68-12-3137
Loading
/content/journal/jgv/10.1099/0022-1317-68-12-3137
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error